FMC Corp (FMC) reported quarterly earnings results on Monday, May-2-2016. The company said it had a profit of $0.58 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.05. Analysts had a consensus of $0.53. The company posted revenue of $798.80 million in the period, compared to analysts expectations of $779.88 million. The company’s revenue was up 21.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.
Many Wall Street Analysts have commented on FMC Corp. Shares were Downgraded by Credit Suisse on Apr 21, 2016 to ” Neutral” and Lowered the Price Target to $ 43 from a previous price target of $45 .FMC Corp was Initiated by Credit Agricole to “Outperform” on Apr 15, 2016.
FMC Corp opened for trading at $43.2 and hit $44.34 on the upside on Wednesday, eventually ending the session at $44.1, with a gain of 1.92% or 0.83 points. The heightened volatility saw the trading volume jump to 12,52,168 shares. Company has a market cap of $5,894 M.
In a different news, on Mar 4, 2016, Mark Douglas (Pres. Agricultural Solutions) sold 10,480 shares at $38.22 per share price. According to the SEC, on Sep 3, 2015, Paul W Graves (CFO) purchased 3,342 shares at $40.84 per share price. On Sep 3, 2015, Vincent R Jr Volpe (director) purchased 12,200 shares at $40.94 per share price, according to the Form-4 filing with the securities and exchange commission.
FMC Corporation is a diversified chemical company. The Company serves agricultural consumer and industrial markets with solutions applications and products around the world. The Company operates in three business segments: FMC Agricultural Solutions FMC Health and Nutrition and FMC Lithium. The Company’s FMC Agricultural Solutions segment develops markets and sells three classes of crop protection chemicals which include insecticides herbicides and fungicides. The FMC Health and Nutrition segment focuses on food pharmaceutical ingredients nutraceuticals personal care and similar markets. The pharmaceutical additives are used for binding encapsulation and disintegrant applications. The Company’s FMC Lithium segment manufactures lithium products.